Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD.

STUDY OBJECTIVE The aim of this study was to investigate the basal level as well as the tumor necrosis factor (TNF)-alpha- and interferon (IFN)-gamma-induced expression and release of the neutrophil chemoattractants interleukin (IL)-8 and growth-related oncogene (GRO)-alpha in primary bronchial epithelial cells (PBECs) from smokers without airflow obstruction and patients with COPD. In addition, the expression of both TNF-alpha-receptor subtypes--p55 TNF-receptor subtype (TNF-R55) and p75 TNF-receptor subtype (TNF-R75)--was quantified in PBECs. DESIGN PBECs from eight smokers without airflow limitation and eight patients with COPD were stimulated with 50 ng/mL of TNF and 200 U/mL of IFN-gamma for 4 h along with unstimulated time controls. The transcriptional expression and protein release were quantitatively assessed by means of real-time polymerase chain reaction and enzyme-linked immunosorbent assay. RESULTS Basal level messenger RNA (mRNA) expression and protein release of IL-8 and GRO-alpha were not significantly different between both groups, although a trend toward higher IL-8 levels was seen in patients with COPD. TNF-alpha induced significantly higher mRNA amounts of IL-8 (p = 0.005) and GRO-alpha (p = 0.007) in patients with COPD. This was accompanied by higher protein release data for IL-8 (p = 0.005) and GRO-alpha (p = 0.007). IFN-gamma had no significant effect on the mRNA expression and protein release of IL-8 and GRO-alpha in either group. TNF-R55 and TNF-R75 were detectable in PBECs. However, no significant differences were found between both groups with respect to steady-state mRNA levels of TNF-alpha-receptor subtypes. CONCLUSION PBECs from patients with COPD show significantly higher TNF-alpha-induced release of the neutrophil chemoattractant CXC-chemokines IL-8 and GRO-alpha compared to smokers without airflow limitation. This increased activation of PBECs may contribute to the predominance of neutrophils seen in the airway lumen of patients with COPD.

[1]  P. Barnes,et al.  Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD , 2002, Thorax.

[2]  L. Fabbri,et al.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[3]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.

[4]  R. Brattsand,et al.  Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. , 2001, The European respiratory journal.

[5]  R. Knuechel,et al.  A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. , 2001, Experimental cell research.

[6]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[7]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[8]  R. Davies,et al.  Effect of Cigarette Smoke on the Permeability and IL-1 β and sICAM-1 Release from Cultured Human Bronchial Epithelial Cells of Never-Smokers, Smokers, and Patients with Chronic Obstructive Pulmonary Disease , 2000 .

[9]  D. Romberger,et al.  Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells. , 2000, International journal of immunopharmacology.

[10]  P. Hiemstra,et al.  Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.

[11]  E. Melillo,et al.  Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. , 1999, American journal of respiratory and critical care medicine.

[12]  H. Hoogsteden,et al.  Interleukin-1beta and interferon-gamma differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells. , 1998, European cytokine network.

[13]  D. Proud,et al.  Epithelia cells as regulators of airway inflammation. , 1998, The Journal of allergy and clinical immunology.

[14]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[15]  P. Jeffery,et al.  Structural and inflammatory changes in COPD: a comparison with asthma. , 1998, Thorax.

[16]  M. Stulbarg,et al.  Obstructive pulmonary disease. The clinician's perspective. , 1998, Radiologic clinics of North America.

[17]  T. Yoneda,et al.  Airway inflammation in COPD assessed by sputum levels of interleukin-8. , 1997, Chest.

[18]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[19]  Anders Lindén.  Increased interleukin‐8 release by β‐adrenoceptor activation in human transformed bronchial epithelial cells , 1996, British journal of pharmacology.

[20]  A. Saalbach,et al.  Novel fibroblast-specific monoclonal antibodies: properties and specificities. , 1996, The Journal of investigative dermatology.

[21]  P. Hiemstra,et al.  Regulation and production of IL‐8 by human proximal tubular epithelial cells in vitro , 1996, Clinical and experimental immunology.

[22]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[23]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[24]  R. Martin,et al.  The effects of inhaled interferon gamma in normal human airways. , 1993, The American review of respiratory disease.

[25]  J. Bousquet,et al.  Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.

[26]  M. Lebowitz,et al.  Epidemiology of chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[27]  Hunninghake Gw,et al.  Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers , 1983 .

[28]  E. C. Hammond,et al.  Relation of smoking and age to emphysema. Whole-lung section study. , 1972, The New England journal of medicine.